Research Archive

Startups Begin Here! Four Startups Awarded $50,000 from TTUHSC President

September 26, 2022

Startups Begin Here! Four Startups Awarded $50,000 from TTUHSC President

The Innovation Hub at Research Park today (September 26, 2022) announced the winners of its annual Presidents' Innovative Startup Awards. The award recognizes startups that have a high potential for growth and an economic impact in West Texas.

Read More

tags: Lubbock, Research, Statline, Stories

TTUHSC Scientist Awarded U.S. Patent to Battle Antibiotic Resistance Using Novel Nanoantibiotics

September 01, 2022

TTUHSC Scientist Awarded U.S. Patent to Battle Antibiotic Resistance Using Novel Nanoantibiotics

Hongjun Liang, Ph.D., said infection poses a significant challenge for both frontline doctors and scientists alike. It’s a challenge he wants to be able to fight by using innovation to develop a new generation of antibiotics.

Read More

tags: Graduate School of Biomedical Sciences, Research, Statline, Stories

Research Identifies, Exploits Vulnerability in Certain High-Risk Cancers

August 10, 2022

Research Identifies, Exploits Vulnerability in Certain High-Risk Cancers

In a study recently published in Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the TTUHSC School of Medicine Cancer Center, sought to expand upon his lab’s previous research.

Read More

tags: Feature Stories, Research, School of Medicine, Statline, Stories

Teaching an Old Drug New Tricks

July 27, 2022

Teaching an Old Drug New Tricks

Sanjay Srivastava, Ph.D., earned a U.S. patent for repurposing an antipsychotic drug to treat various types of cancer.

Read More

tags: Research, School of Pharmacy, Statline, Stories

Snail Fever Vaccine Reaches First Human Clinical Trial

June 10, 2022

Snail Fever Vaccine Reaches First Human Clinical Trial

A preventative vaccine for major tropical disease schistosomiasis has reached a Phase 1 clinical trial, providing a dose for the first healthy human volunteer.

Read More

tags: Research, School of Medicine, Statline, Stories

Gene Sequencing an Important Tool in COVID-19 Battle

June 09, 2022

Gene Sequencing an Important Tool in COVID-19 Battle

Gene sequencing, a process of determining the sequential order of the building blocks that make up a strand of DNA, is used to keep pace with the constantly moving target that is COVID-19.

Read More

tags: Research, School of Medicine, Statline, Stories

TTUHSC Research Receives Prestigious Status as Carnegie Classification® for Special Focus Four-Year Research Institution

May 11, 2022

TTUHSC Research Receives Prestigious Status as Carnegie Classification® for Special Focus Four-Year Research Institution

The Carnegie Classification® of Institutions of Higher Education has designated Texas Tech University Health Sciences Center (TTUHSC) as a Special Focus Four-Year Research Institution.

Read More

tags: Feature Stories, Research, Statline, Stories, TTUHSC in the News

TTUHSC’s Reynolds Receives CPRIT Research Grant to Study Childhood Cancers

April 12, 2022

TTUHSC’s Reynolds Receives CPRIT Research Grant to Study Childhood Cancers

CPRIT awarded a four-year, $1.34 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at the Texas Tech University Health Sciences Center.

Read More

tags: Feature Stories, Research, School of Medicine, Statline, Stories

Bridging Academia and Industry to Advance Drone Technologies

April 07, 2022

Bridging Academia and Industry to Advance Drone Technologies

Alongside Texas Tech University and 2THEDGE, a leading technology consulting and investing firm, TTUHSC unveiled the groundwork of a future public-private collaboration supporting the advancement of Unmanned Aerial Systems (UAS) research at a summit event on the TTUHSC campus Wednesday, April 6.

Read More

tags: Research, Statline, Stories, Vision

Pharmacy Researchers Receive Patent for Chemical Probe

March 29, 2022

Pharmacy Researchers Receive Patent for Chemical Probe

Nadia German, Ph.D., and collaborator Constantinos Mikelis, Ph.D., have received a U.S. patent for a chemical that targets the brain’s dopamine transporter.

Read More

tags: Research, School of Pharmacy, Statline

categories


Complete Story Archive